Quick Answer
Ashwagandha and Stress has evidence relevant to safety, limits, and clinician-discussion contexts, but conclusions should stay close to the cited sources. One representative finding is: There is a paucity of evidence assessing the efficacy and safety of low-dose formulations of Ashwagandha in stress management.
Key Takeaways
- 01There is a paucity of evidence assessing the efficacy and safety of low-dose formulations of Ashwagandha in stress management. [Thanawala Shefali (2026)]
- 02We evaluated the efficacy and safety of AshwaSR capsules at doses of 150 and 300 mg in reducing stress and associated symptoms in healthy adults experiencing stress, over a period of 60 days of administration. [Thanawala Shefali (2026)]
- 03Items were designed to determine how unpredictable, uncontrollable, and overloaded subjects found their lives, with response scores ranging between 0 and 40 (scores 0–13, low; 14–26, moderate; 27–40, high perceived stress). [Thanawala Shefali (2026)]
- 041 2 [,] 3 4 [,] 5 [] Stress is a normal response to difficult situations in an individual’s life; however, prolonged and excessive mental or physical stress can be detrimental. [Thanawala Shefali (2026)]
The current Migaku evidence database contains 2 reusable source documents for Ashwagandha and Stress. This answer focuses on safety, limits, and clinician-discussion contexts.
- There is a paucity of evidence assessing the efficacy and safety of low-dose formulations of Ashwagandha in stress management. [Thanawala Shefali (2026); evidence level 2]
- We evaluated the efficacy and safety of AshwaSR capsules at doses of 150 and 300 mg in reducing stress and associated symptoms in healthy adults experiencing stress, over a period of 60 days of administration. [Thanawala Shefali (2026); evidence level 2]
- Items were designed to determine how unpredictable, uncontrollable, and overloaded subjects found their lives, with response scores ranging between 0 and 40 (scores 0–13, low; 14–26, moderate; 27–40, high perceived stress). [Thanawala Shefali (2026); evidence level 2]
- 1 2 [,] 3 4 [,] 5 [] Stress is a normal response to difficult situations in an individual’s life; however, prolonged and excessive mental or physical stress can be detrimental. [Thanawala Shefali (2026); evidence level 2]
- These limitations have catalyzed an increased global focus on nutraceuticals and phytomedicines possessing multimodal biological activities that transcend mere monoamine reuptake inhibition. [Li Xikun (2026); evidence level 3]
Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording.
This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.
Sources
- Efficacy and safety of Ashwagandha root extract sustained-release (AshwaSR) capsules in healthy adult, stressed subjects: A randomized, double-blind, placebo-controlled, parallel-group, 3-arm clinical trial
- Rhodiola rosea , Ginkgo biloba , and Ashwagandha as novel antidepressant supplements: converging monoaminergic, neurotrophic, anti-inflammatory, and brain health pathways in depressive disorders